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In this work, we propose natural rubber latex (NRL) membranes as a protein delivery system. For this purpose 
Bovine Serum Albumin (BSA) was incorporated into the latex solution for in vitro protein delivery experiments. 
Different polymerization temperatures were used, from –10 to 27 °C, in order to control the membrane morphology. 
These membranes were characterized by Scanning Electron Microscopy (SEM), Atomic Force Microscopy (AFM), 
as well as the Lowry Method to measure the BSA release. SEM and AFM microscopy analysis showed that the 
number, size and distribution of pores in NRL membranes can be varied, as well as its overall morphology. We 
have found that the morphology of the membrane is the predominant factor for higher protein release, compared 
with pore size and number of pores. Results demonstrated that the best drug-delivery system was the membrane 
polymerized at RT (27 °C), which does release 66% of its BSA content for up to 18 days. Our results indicate 
that NRLb could be used in the future as an active membrane that could accelerate bone healing in GBR.
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1. Introduction
Natural rubber latex (NRL) extracted from Hevea brasiliensis 
has been widely used in the manufacturing of gloves, condoms, bal-
loons, and parts of medical and dental equipment1-4. Typically for 
those applications, the processing of NRL was basically the same 
as those found in the tyres industry. However recently, several new 
biomedical applications for NRL have been proposed using a differ-
ent manufacturing process (NRLb)5-9. Of special interest, NRLb has 
shown to stimulate angiogenesis, cellular adhesion and the formation 
of extracellular matrix10, promoting the replacement and regenera-
tion of tissue11.
It is well known in the literature that NRL can give allergic 
reactions and has cytoxicity problems, which is of great concern 
especially on these new applications where NRL is used inside the 
human body. However NRLb is processed avoiding the use of chemi-
cals such as carbamates and sulphur, as well as does not suffer any 
heat treatments. Apparently this way of producing NRLb produces 
a much better biocompatible material. In fact, NRLb is now com-
mercialized in Brazil and other 60 countries as a band-aid curative 
(BIOCURE®) for the treatment of ulcers in diabetic patients among 
other applications12. 
In a previous study, we have tested NRLb as an occlusive mem-
brane for Guided Bone Regeneration (GBR) with promising results13. 
We tested our membrane in a critical defect in the rabbit calvaria, 
and did show that the wound was healed only with NRLb. NRLb 
worked as a passive barrier membrane that prevented epithelial and 
connective tissue migration, thus facilitating the proliferation and 
migration of regenerative potential cells, such as bone cells, into the 
protected wound. One possible way to accelerate bone regeneration 
would be to incorporate bone morphogenetic protein (BMPs) in 
NRLb. BMPs have strong bone-inductive activity and many works 
have been dedicated to the development of delivery systems that 
sustain their gradual release for dental and orthopedic uses14-17. One 
key issue in this particular problem is that bone regeneration is a long 
term processes, typically in humans of the order of 8-16 weeks18-21. 
Thus the ideal membrane would have to release BMPs along many 
weeks. So in this work we have used different polymerization condi-
tions in order to control the protein release of NRLb. Instead of using 
BMPs, in our study we used BSA that has similar molecular weight 
however is cheaper. NRLb polymerized under different conditions, 
and with the incorporation of BSA was characterized by Scanning 
Electron Microscopy (SEM) and Atomic Force Microscopy (AFM), 
while BSA release from the membrane was characterized by the 
Lowry Method22,23. Results demonstrated that the NRLb membrane 
can release BSA for up to 18 days. 
2. Experimental Section
The latex solution used in this work consisted of a mixture of a 
noncontrolled variety of clones extracted from Hevea brasiliensis. The 
latex solution was provided by ESALQ-USP, Piracicaba, Brazil. After 
extraction, ammonia was used to keep the latex liquid, and this mate-
rial was centrifuged at 8000 g. The centrifugation was employed to 
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reduce the natural protein content of NRLb10. Bovine Serum  Albumin 
(BSA) was purchased from INLAB Ltd., Brazil. 
Two types of membranes were used: A) NRLb (2 mL of natu-
ral rubber) and; B) NRLbBSA (2 mL of natural rubber + 1 mL of 
BSA solution (10 mg.mL–1)). These membranes were prepared by 
pouring the latex or latex+BSA solution in a stainless steel plate 
with 5.00 ± 0.05 cm diameter, and left at different temperatures for 
polymerization: 27 °C (Room temperature), –1 °C, and –10 °C. Typi-
cally the membranes were left for 02 days to fully polymerize before 
use. The temperatures chosen are known to change the porosity of 
the membranes24,25.
For the protein release study NRLb and NRLbBSA membranes 
were placed in 200 mL of aqueous solution, where the release be-
havior was observed. Aliquots of this solution were collected during 
an interval ranging from 10 to 24,000 minutes. We determined the 
protein release as a function of time using the Lowry Method.26,27. To 
determine the concentration of BSA released into the solution it was 
necessary to take into account that NRLb does also release proteins 
that absorb at the same wavelength as the BSA. Thus the NRLb release 
curve was subtracted from the NRLbBSA release curve. 
The pore distribution in NRLb membrane was observed using 
a Scanning Electron Microscocopy (SEM) model Zeiss® EVO 50 
(15 KV). The surface topography of the NRL membrane was exam-
ined in a Shimadzu® SPM-9600 operating in the tapping mode (scan 
size 25 and 50 μm). The average roughness (Ra) of the substrate 
surface was directly calculated from the AFM image. 
3. Results and Discussion
Figure 1 shows typical SEM images of membranes polymer-
ized at different temperatures. As can be seen the pore sizes and 
density vary with polymerization temperature. NRLb polymerized 
at RT (Figure 1a), has apparently no pores, while those membranes 
polymerized at –1 °C and –10 °C do have. The density of pores is 
higher as the polymerization temperature diminishes. Pore sizes 
with diameters ranging from 0.50 to 1.63 μm, were observed on the 
NRLb membrane polymerized at –1 °C (Figure 1b), while the film 
polymerized at –10 °C displayed pore sizes of similar dimensions 
(~0.86 ± 0.12) μm (Figure 1c).
Figures 2a and 2b shows AFM images of membranes polymerized 
at RT and –1 °C, respectively. The image of the membrane polymer-
ized at –10 °C is similar to Figure 2b, and thus not shown. As can be 
seen in Figure 2a, the polymer structure in this case is characterized 
by linear chains, or linear bundles of chains, whereas in Figure 2b 
these linear chains are not seen. The appearance of linear chains is 
followed by a higher surface roughness, see insets of Figure 2.
In Figure 3 BSA release as a function of time is presented for 
membranes polymerized in similar conditions to the ones presented 
in Figure 1. In the inset of this figure, the release rate is also presented 
until the saturation point. The concentration of released BSA increases 
asymptotically for all samples. The release from the membrane 
polymerized at RT is higher than those polymerized at –1 °C and at 
–10 °C. The 3 membranes reach saturation at different concentrations. 
In the other words, the total concentration of released BSA depends 
on the latex polymerization temperature. 
As already mentioned in the introduction, the main concern of 
this study was to optimize the BSA release in small rates. Accord-
ing to Woo17, sustained release implants induce better bone healing 
compared with those that do not. 
Based on SEM results (Figure 1), we observed that the pore size 
and number can affect the BSA release. No pores were observed on 
the NRLb membrane polymerized at RT, and it had the highest BSA 
release. Therefore our results indicate that the way the chains are 
organized during polymerization is the dominant factor concerning 
protein release. The formation of pores may correlate with a higher 
cross-linking, forming in fact a denser matrix for BSA release (NRLb 
membranes polymerized at –1 °C and –10 °C). 
The experimental data in Figure 3 were fitted by Double rec-
tangular hyperbola function. After integration of these curves until 
285 hours, the total amount of BSA released by the three membranes 
in 200 mL aqueous solution were: 13.24 mg (44.1% of the BSA used 
in the beginning) for RT membrane and 3,73 mg (12.4%) for –1 °C 
and 7,52 mg (25.1%) for-10 °C membranes respectively. After 18 days 
the NRLb membrane polymerized at RT released 20.54 mg of BSA, 
or 68.4% of the amount used during polymerization.
As mentioned earlier the controlled release of proteins are of 
interest for medical applications, since the dose can be adjusted ac-
cording to the necessity of the patient. Our results indicate that with 
very simple changes in NRLb preparation we could control BSA 
release up to 18 days, thus making them promising materials for 
protein release for in vivo applications28-31. 
(a) (b) (c)
Figure 1. SEM images (magnification: x 10,000) of NRLb membranes a) Polymerized at RT, b) Polymerized at –1 °C and c) Polymerized at –10 °C. Notice 
the difference in the size pores. 
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4. Conclusion
We have prepared natural rubber latex membranes containing 
BSA as a model system for Guided Bone Regeneration (GBR). 
Membranes prepared at different polymerization temperatures were 
analyzed. SEM and AFM microscopy analysis showed that the po-
lymerization temperature has a strong influence on pore distribution. 
By decreasing the temperature the pore density increases. In fact for 
membranes prepared at RT, no pores could be seen with a magnifi-
cation of 10,000. However the RT membrane was characterized by 
structures that indicate the formation of linear bundles of chains. In 
what concerns BSA release the presence of this linear bundles was 
responsible for a higher release rate. Results demonstrated that the 
NRLb membrane polymerized at RT can release BSA for 18 days. 
Our results indicate that NRLb could be used in the future as an active 
membrane that could accelerate bone healing in GBR. 
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